We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Overcoming Challenges in Biopharma: Transformational Innovation is Key

Article   Jan 07, 2019 | by Lisa Sapp (Biopharma Market Manager, Agilent Technologies) and Ning Tang (Biopharma Segment Marketing Manager, Agilent Technologies)

 
Overcoming Challenges in Biopharma: Transformational Innovation is Key
 
 
 

RELATED ARTICLES

Key Themes and Conversations From the First Lab of the Future Congress

Article

What do we mean by lab of the future? What innovations are required to get there? These are the key themes explored by this year's Lab of the Future Congress, summarized in this article.

READ MORE

Keeping Up With the Fentanyls

Article

If the rapid migration of deadly fentanyls wasn’t difficult to keep up with already, they are also evading analysts through their chemistry. Due to an inexpensive and flexible production process, unique versions of the synthetic opioids are regularly cooked up by illicit chemists, creating new dangers for consumers and new headaches for toxicologists.

READ MORE

Could Cannabinoids Be Used To Treat PTSD?

Article

Effective treatments for post-traumatic stress disorder (PTSD) have proved extremely elusive to researchers. For some, the legalisation of cannabis could present an opportunity to develop new therapies for PTSD.We talked to Allied Corp’s CEO Calum Hughes about cannabis’s potential for PTSD therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE